Structural and Regulatory Changes in PBP4 Trigger Decreased β-Lactam Susceptibility in Enterococcus faecalis

ABSTRACT Enterococcus faecalis strains resistant to penicillin and ampicillin are rare and have been associated with increases in quantities of low-affinity penicillin-binding protein 4 (PBP4) or with amino acid substitutions in PBP4. We report an E. faecalis strain (LS4828) isolated from a prosthetic knee joint that was subjected to long-term exposure to aminopenicillins. Subsequent cultures yielded E. faecalis with MICs of penicillins and carbapenems higher than those for wild-type strain E. faecalis JH2-2. Sequence analysis of the pbp4 gene of LS4828 compared to that of JH2-2 revealed two point mutations with amino acid substitutions (V223I, A617T) and deletion of an adenine from the region upstream of the predicted pbp4 −35 promoter sequence (UP region). Purified PBP4 from LS4828 exhibited less affinity for Bocillin FL than did PBP4 from JH2-2, which was recapitulated by purified PBP4 containing only the A617T mutation. Differential scanning fluorimetry studies showed that the LS4828 and A617T variants are destabilized compared to wild-type PBP4. Further, reverse transcription-PCR indicated increased transcription of pbp4 in LS4828 and Western blot analysis with polyclonal PBP4 antibody revealed greater quantities of PBP4 in LS4828 than in JH2-2 lysates and membrane preparations. Placing the promoter regions from LS4828 or JH2-2 upstream of a green fluorescent protein reporter gene confirmed that the adenine deletion was associated with increased transcription. Together, these data suggest that the reduced susceptibility to β-lactam antibiotics observed in E. faecalis LS4828 results from a combination of both increased expression and remodeling of the active site, resulting in reduced affinity for penicillins and carbapenems. IMPORTANCE Enterococcus faecalis is an important cause of community-acquired and nosocomial infections and creates therapeutic dilemmas because of its frequent resistance to several classes of antibiotics. We report an E. faecalis strain with decreased ampicillin and imipenem susceptibility isolated after prolonged courses of aminopenicillin therapy for a prosthetic joint infection. Its reduced susceptibility is attributable to a combination of increased quantities of low-affinity PBP4 and an amino acid substitution in proximity to the active site that destabilizes the protein. Our findings provide a cautionary tale for clinicians who elect to “suppress” infections in prosthetic joints and offer novel insights into the interaction of β-lactam antibiotics with low-affinity PBP4. These insights will help inform future efforts to develop therapeutics capable of inhibiting clinical enterococcal strains. Enterococcus faecalis is an important cause of community-acquired and nosocomial infections and creates therapeutic dilemmas because of its frequent resistance to several classes of antibiotics. We report an E. faecalis strain with decreased ampicillin and imipenem susceptibility isolated after prolonged courses of aminopenicillin therapy for a prosthetic joint infection. Its reduced susceptibility is attributable to a combination of increased quantities of low-affinity PBP4 and an amino acid substitution in proximity to the active site that destabilizes the protein. Our findings provide a cautionary tale for clinicians who elect to “suppress” infections in prosthetic joints and offer novel insights into the interaction of β-lactam antibiotics with low-affinity PBP4. These insights will help inform future efforts to develop therapeutics capable of inhibiting clinical enterococcal strains.

[1]  A. L. Darini,et al.  Evaluation of polymorphisms in pbp4 gene and genetic diversity in penicillin-resistant, ampicillin-susceptible Enterococcus faecalis from hospitals in different states in Brazil. , 2016, FEMS microbiology letters.

[2]  J. Gatell,et al.  Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[3]  Dong Xu,et al.  FFAS-3D: improving fold recognition by including optimized structural features and template re-ranking , 2014, Bioinform..

[4]  J. De La Torre,et al.  Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  L. Rice,et al.  Early Insights into the Interactions of Different β-Lactam Antibiotics and β-Lactamase Inhibitors against Soluble Forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3 , 2012, Antimicrobial Agents and Chemotherapy.

[6]  Cesar A. Arias,et al.  The rise of the Enterococcus: beyond vancomycin resistance , 2012, Nature Reviews Microbiology.

[7]  C. Wolz,et al.  High-Level Fluorescence Labeling of Gram-Positive Pathogens , 2011, PloS one.

[8]  L. Rice,et al.  Analysis of PBP5 of Early U.S. Isolates of Enterococcus faecium: Sequence Variation Alone Does Not Explain Increasing Ampicillin Resistance over Time , 2011, Antimicrobial Agents and Chemotherapy.

[9]  Rebecca Page,et al.  Strategies to maximize heterologous protein expression in Escherichia coli with minimal cost. , 2007, Protein expression and purification.

[10]  S. Ono,et al.  Mechanisms of Resistance to Imipenem and Ampicillin in Enterococcus faecalis , 2005, Antimicrobial Agents and Chemotherapy.

[11]  P. Caspers,et al.  Structure-Activity Relationships of Different β-Lactam Antibiotics against a Soluble Form of Enterococcus faecium PBP5, a Type II Bacterial Transpeptidase , 2005, Antimicrobial Agents and Chemotherapy.

[12]  P. Caspers,et al.  Impact of Specific pbp5 Mutations on Expression of β-Lactam Resistance in Enterococcus faecium , 2004, Antimicrobial Agents and Chemotherapy.

[13]  W. Zorzi,et al.  The penicillin resistance of Enterococcus faecalis JH2-2r results from an overproduction of the low-affinity penicillin-binding protein PBP4 and does not involve a psr-like gene. , 2001, Microbiology.

[14]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[15]  S. D. Kahl,et al.  BOCILLIN FL, a Sensitive and Commercially Available Reagent for Detection of Penicillin-Binding Proteins , 1999, Antimicrobial Agents and Chemotherapy.

[16]  R. Gourse,et al.  Identification of an UP element consensus sequence for bacterial promoters. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Fontana,et al.  Modification of penicillin-binding protein 5 associated with high-level ampicillin resistance in Enterococcus faecium , 1996, Antimicrobial agents and chemotherapy.

[18]  G. Weinstock,et al.  Generation of auxotrophic mutants of Enterococcus faecalis , 1995, Journal of bacteriology.

[19]  W. Graninger,et al.  Nosocomial bacteremia due to Enterococcus faecalis without endocarditis. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  L. Rice,et al.  Chromosomally mediated beta-lactamase production and gentamicin resistance in Enterococcus faecalis , 1991, Antimicrobial Agents and Chemotherapy.

[21]  B. Murray The life and times of the Enterococcus , 1990, Clinical Microbiology Reviews.

[22]  D. Shlaes,et al.  Inducible resistance to vancomycin in Enterococcus faecium D366. , 1989, The Journal of infectious diseases.

[23]  P. Longoni,et al.  Identification of a streptococcal penicillin-binding protein that reacts very slowly with penicillin , 1983, Journal of bacteriology.

[24]  B. White,et al.  Modification of Streptococcus faecalis sex pheromones after acquisition of plasmid DNA. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Hanahan Studies on transformation of Escherichia coli with plasmids. , 1983, Journal of molecular biology.

[26]  A. Jacob,et al.  Conjugal Transfer of Plasmid-Borne Multiple Antibiotic Resistance in Streptococcus faecalis var. zymogenes , 1974, Journal of bacteriology.

[27]  W. J. Martin,et al.  Antibiotic Therapy of Bacterial Endocarditis: VI. Subacute Enterococcal Endocarditis Clinical, Pathologic and Therapeutic Consideration of 33 Cases , 1954, Circulation.